Trump says he is 'more angry' than ever as he kicks off his 2024 presidential campaign
- Donald Trump said he is "more angry" than ever before as he kicked off his 2024 campaign.
- He spoke at events with party leaders in New Hampshire and South Carolina on Saturday.
Former President Donald Trump said he is "more angry" than ever before, as he officially kicked off his 2024 campaign with visits to New Hampshire and South Carolina on Saturday.
While speaking at the New Hampshire Republicans' annual meeting in Salem, Trump rejected claims that his campaign has lost momentum.
"They said, 'He's not doing rallies, he's not campaigning, maybe he's lost that step,'" Trump said at the New Hampshire GOP's annual meeting in Salem, his first event.
"I'm more angry now, and I'm more committed now than I ever was."
The former president went on to promise that "we have huge rallies planned, bigger than ever before" while speaking later in Columbia, South Carolina, according to The Associated Press.
The two events in the early-voting states were more muted than the large rallies he held during his 2016 and 2020 presidential runs.
In Columbia, South Carolina, the former president spoke to a crowd of around 200 people in the state's Capitol building, with Governor Henry McMaster and Senator Lindsey Graham of South Carolina appearing with him, per Reuters.
Trump is so far the only Republican to announce their candidacy for 2024. Since his announcement, Trump's campaign has appeared to be off to a slow start amid reports suggesting that he is losing support among voters.
On Saturday, Trump also took aim at Florida Governor Ron DeSantis, who is shaping up to be his most formidable political rival, by criticizing his COVID-19 record.
He told AP that it would be "a great act of disloyalty" if DeSantis decided to run against him.
- Fuel your morning: Wholesome South Indian breakfast ideas for health
- Vodafone Idea shares tumble 14%, mcap erodes ₹10,806.7 cr
- National parties declare income of ₹3,077 cr in 2022-23; BJP has highest share
- Human trials may reveal efficacy of new Rs 100 cancer pill: Docs
- Multiplexes' revenue growth to dip to 15% in FY25 as OTTs crimp profit margins